In this episode of Real World Talk we welcome Su Huang, the Head of Data Strategy at Datavant. Su shares real-world experiences implementing enterprise data strategies and the efficiencies that can be gained when teams across an organization are involved in the process.

Unlike the controlled settings under which clinical trials are conducted, real-world data is collected from a variety of settings. The FDA recently released draft guidance on how to use real-world data for regulatory submissions. Our team of clinical experts discuss this guidance and its effect on how we generate and apply RWD in clinical development.

Almost 10% of the world’s population suffers from a type of blood cancer. And despite popular opinion, there are actually hundreds of different types of blood cancer, not just leukemia and lymphoma. But are we doing everything in our power when developing clinical trials to improve cancer treatment? Could we include diversity and make trials more accessible to everyone? Our guest today thinks we have more work to do in the blood cancer space. In this episode of the Real World Talk podcast, our host Miruna Sasu welcomes Dr.Gwen Nichols, Executive Vice President and Chief Medical Officer of The Leukemia & Lymphoma Society (LLS). We discuss the importance of making clinical trials more diverse and feasible for patients. We also get into Dr. Gwen’s predictions for the future and why she thinks there’s hope for earlier cancer detection and prevention.

In today’s Real World Talk podcast episode, our host Zoe Li welcomes Esther Krofah, the Executive Director at FasterCures. Esther talks about the lessons they as an organization have learned during the pandemic. She also discusses the importance of real world-data and says, although all studies start in a controlled environment, authentic results come when trials are applied to real-world settings.

In this episode of the Real World Talk podcast, our host Drew Belli introduces Donna Rivera, the Associate Director for Pharmacoepidemiology, RWD & RWE at FDA Oncology Center of Excellence. Donna is a pharmacist and pharmacoepidemiologist with over ten years of clinical pharmacy, data science, and research expertise across government, academia, and industry enterprise. She’s passionate about cultivating collaborations that facilitate real-world data (RWD) transformation into real-world evidence (RWE) in Oncology to meaningfully improve drug development and outcomes for patients.

In this episode of the Real World Talk podcast, Kevin Keogh talks to Matthew Ong, the Associate Editor at The Cancer Letter. With over eight years of experience in writing investigative and enterprise stories about oncology, cancer informatics, drug development, and medical devices, Matt has a direct insight into the industry and works alongside some of the smartest people in the field.